116 related articles for article (PubMed ID: 8572573)
1. Lysozyme stimulates lymphocyte response to ConA and IL-2 and potentiates 5-fluorouracil action on advanced carcinomas.
Sava G; Pacor S; Dasić G; Bergamo A
Anticancer Res; 1995; 15(5B):1883-8. PubMed ID: 8572573
[TBL] [Abstract][Full Text] [Related]
2. Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma.
Pacor S; Giacomello E; Bergamo A; Clerici K; Zacchigna M; Boccu E; Sava G
Anticancer Res; 1996; 16(5A):2559-64. PubMed ID: 8917351
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of GALT and activation of mesenteric lymph node lymphocytes by a modified lysozyme in CBA mice with MCa mammary carcinoma.
Sava G; Bergamo A; Capozzi I; Clerici K; Pacor S; Gagliardi R; Giacomello E; Zacchigna M; Di Luca G; Boccu E
J Exp Ther Oncol; 1996 Nov; 1(6):342-9. PubMed ID: 9414423
[TBL] [Abstract][Full Text] [Related]
4. Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse.
Sava G; Ceschia V; Pacor S; Zorzet S; Perissin L
Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):683-9. PubMed ID: 2622298
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic effects of egg-white lysozyme in mice bearing solid metastasizing tumors.
Sava G; Perissin L; Zorzet S; Callerio C
Anticancer Res; 1986; 6(2):183-6. PubMed ID: 3707053
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of the antineoplastic action of lysozyme: evidence for host mediated effects.
Sava G; Ceschia V; Pacor S
Anticancer Res; 1989; 9(4):1175-80. PubMed ID: 2817798
[TBL] [Abstract][Full Text] [Related]
7. Cytofluorimetric analysis of gut-intraepithelial and mesenteric lymph node lymphocytes of tumour bearing mice fed with egg-white lysozyme.
Pacor S; Giacomello E; Bergamo A; Gagliardi R; Cocchietto M; Sava G
Anticancer Res; 1996; 16(1):145-9. PubMed ID: 8615600
[TBL] [Abstract][Full Text] [Related]
8. [Experimental studies on antitumor effects of lysozyme].
Fukawa K; Nishimura N; Irino O; Nakazato K; Taguchi A; Nitta K
Gan To Kagaku Ryoho; 1982 May; 9(5):915-23. PubMed ID: 7184434
[TBL] [Abstract][Full Text] [Related]
9. Observations on the antimetastatic action of lysozyme in mice bearing Lewis lung carcinoma.
Sava G; Ceschia V; Pacor S; Zabucchi G
Anticancer Res; 1991; 11(3):1109-13. PubMed ID: 1888145
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
11. [Subcutaneous transplantation of microencapsulated Chinese hamster ovary (CHO) cells/pcDNA 3.1/mIL-12 and subcutaneous transplantation of microencapsulated CHO/pcDNA3.1/mIL-12 combined with 5-fluoro-uracil in treatment of tumor-burdened mice].
Pan YL; Zheng S; Xiao ZX; Cao J; Yao HP
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):51-4. PubMed ID: 12757646
[TBL] [Abstract][Full Text] [Related]
12. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
[TBL] [Abstract][Full Text] [Related]
13. [Experimental studies on antitumor effects of lysozyme-II. Effect of lysozyme on immunopotentiation].
Fukawa K; Nishimura N; Irino O; Nitta K
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1832-7. PubMed ID: 7184377
[TBL] [Abstract][Full Text] [Related]
14. Modulation of murine macrophages and T lymphocytes by lysozyme dimer.
Obmińska-Mrukowicz B; Szczypka M; Gaweda B
Pol J Vet Sci; 2002; 5(4):237-41. PubMed ID: 12512557
[TBL] [Abstract][Full Text] [Related]
15. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma.
Baral R; Chattopadhyay U
Int Immunopharmacol; 2004 Mar; 4(3):355-66. PubMed ID: 15037213
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pretreatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapy.
Lissoni P; Brivio F; Fumagalli L; Di Fede G; Brera G
In Vivo; 2005; 19(6):1077-80. PubMed ID: 16277025
[TBL] [Abstract][Full Text] [Related]
17. [Anti-tumor effect of monkshood polysaccharide with adriamycin long circulating temperature-sensitive liposome and its mechanism].
Dong LF; Zhang YJ; Liu JS; Song SX; Hou J; Lu ZJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):458-62. PubMed ID: 16806008
[TBL] [Abstract][Full Text] [Related]
18. Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice.
Orucevic A; Lala PK
Cell Immunol; 1996 Apr; 169(1):125-32. PubMed ID: 8612285
[TBL] [Abstract][Full Text] [Related]
19. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS).
Akarid K; Pocidalo MA; Desforges B; Sinet M
Eur Cytokine Netw; 1995; 6(3):181-5. PubMed ID: 8589275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
